TWLO:NYSETwilio Inc. Analysis
Data as of 2026-05-27 - not real-time
$181.57
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock trades above its short‑term and mid‑term moving averages, indicating bullish momentum. RSI sits near the mid‑range, suggesting neither overbought nor oversold. MACD histogram is negative, with the MACD line below its signal, pointing to short‑term bearish pressure. Volume trend is decreasing, which could limit upside. Volatility is high, reflecting a wide price swing range. Beta is elevated, implying higher systematic risk.
The trailing P/E is extremely high relative to the industry average, suggesting the stock is priced for strong growth. Forward P/E is more moderate, aligning with projected earnings improvements. A discounted cash flow model yields a fair value modestly above the current price, indicating limited upside. Market sentiment is in extreme greed mode, which could fuel short‑term buying. Revenue growth remains solid with improving margins and positive free cash flow. Analyst consensus leans toward a buy recommendation.
The trailing P/E is extremely high relative to the industry average, suggesting the stock is priced for strong growth. Forward P/E is more moderate, aligning with projected earnings improvements. A discounted cash flow model yields a fair value modestly above the current price, indicating limited upside. Market sentiment is in extreme greed mode, which could fuel short‑term buying. Revenue growth remains solid with improving margins and positive free cash flow. Analyst consensus leans toward a buy recommendation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages
- Negative MACD histogram
- Decreasing volume trend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Solid revenue growth and margin expansion
- Positive free cash flow generation
- DCF fair value indicating modest upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic AI positioning and platform expansion
- Recurring revenue model with high customer stickiness
- Analyst consensus and forward earnings outlook
Key Metrics & Analysis
Financial Health
Revenue Growth20.00%
Profit Margin1.96%
P/E Ratio275.1
ROE1.32%
ROA1.67%
Debt/Equity13.72
P/B Ratio3.5
Op. Cash Flow$965.4M
Free Cash Flow$879.9M
Industry P/E40.4
Technical Analysis
TrendBullish
RSI53.9
Support$139.06
Resistance$203.71
MA 20$187.67
MA 50$153.90
MA 200$127.41
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34
Valuation
Fair Value$181.07
Target Price$195.09
Upside/Downside7.44%
GradeFair
TypeGrowth
Risk Assessment
Beta1.45
Volatility76.81%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.